News en2019-07-25T12:18:03+02:00


Brandl & Talos advises Series D investors on EUR 40 million financing round for Themis Bioscience

Themis Bioscience announced the closing of a EUR 40 million Series D financing round. Brandl & Talos advised the Series D investor consortium consisting of (1) Farallon Capital, (2) Adjuvant Capi-tal, (3) Global Health Investment Fund, (4) Hadean Ventures, (5) Omnes Capital, (6) Ventech, (7) Wellington Partners Life Sciences und (8) aws Gründerfonds on one of the largest VC financing rounds in Austria to date in 2019.

23. September 2019|

News on the Regulation of Crypto-Financial Services

German legislator subjects cryptosafe custody business to the BaFin supervision. As part of the implementation of the 5th Money Laundering Directive (Directive (EU) 2018/843), the German legislator plans to classify the so-called "cryptosafekeeping business" as a financial service in accordance with the German Banking Act. Written by Nicholas Aquilina & Simon Ewerz.

19. September 2019|

Cash Pooling – What to look out for

Cash pooling refers to the needs-based distribution of liquid funds within a group. Surplus cash of solvent group companies is bundled into a central "pool" (an operating company) and then dis-tributed to the group companies in need of liquidity. Learn more in this article written by Christopher Schrank & Aaaron Kleinbord.

3. September 2019|